Vemanti Group Announces Corporate Updates and Developments
July 01, 2020 08:30 ET | Vemanti Group, Inc
IRVINE, Calif., July 01, 2020 (GLOBE NEWSWIRE) -- Vemanti Group, Inc. (OTC PINK:VMNT) a multi-asset technology-driven company, today provided its corporate updates and developments. The Company’s Q2...
Corbus Pharmaceuticals Reports First Quarter Financial Results and Corporate Updates
May 11, 2020 07:05 ET | Corbus Pharmaceuticals Holdings, Inc.
Topline results for lenabasum Phase 3 RESOLVE-1 study in systemic sclerosis remain on schedule for summer of 2020, followed by Phase 2b study data in cystic fibrosis Phase 1 trial of CRB-4001 remains...
Corbus Pharmaceuticals Reports 2019 Third Quarter Financial Results and Provides Clinical and Corporate Updates
November 07, 2019 07:05 ET | Corbus Pharmaceuticals Holdings, Inc.
Phase 3 “RESOLVE-1” study of lenabasum for treatment of systemic sclerosis on track for topline results in summer of 2020Systemic sclerosis is a rare autoimmune disease affecting ~200,000 people in...
Bullfrog Gold Receives Nevada Permits and Provides Corporate and Project Updates
July 15, 2019 06:00 ET | Bullfrog Gold Corp
GRAND JUNCTION, Colo., July 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Bullfrog Gold Corp (OTCQB: BFGC) (“BFGC” or the “Company”) is pleased to announce issuance of environmental permits and...
Vitality New.png
Vitality Biopharma Announces Corporate Updates and Completion of an SEC Examination
November 21, 2018 07:00 ET | Vitality Biopharma, Inc
Company appoints two new directors including the Hon. Edward Feighan as new Chairman of the Board LOS ANGELES, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Vitality Biopharma, Inc. (OTCQB: VBIO)...